Evotec SE

Evotec SE to announce results for first quarter 2024 on 22 may 2024

Evotec SE: Dr. Cord Dohrmann, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2023 pursuant Evotec’s remuneration system.

Evotec SE: Bekanntmachung der Einberufung zur Hauptversammlung am 10.06.2024 in Hamburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

Bayer and Evotec collaborate to advance precision cardiology

Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth

Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments

Evotec SE to announce results for fiscal year 2023 on 24 April 2024

Evotec welcomes Aurélie Dalbiez as Chief People Officer

Evotec and Claris Ventures streamline access to accelerate programmes from Claris’s portfolio companies into the clinic

Evotec SE: Dr. Cord Dohrmann, sell

Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV